Skip to main content

Braslyn Ltd.

SEC CIK
0001642355
Latest filing
Feb 14, 2025

The latest 13F from Braslyn Ltd. covers Q4 2024 (filed Feb 14, 2025): 1 long positions worth $7.81M. The top 10 holdings make up 100.0% of the portfolio, and the largest is Inseego Corp. (INSG) at 100.0%. Livermore has 5 filings on Form 13F from this institution, going back to Q4 2023.

What changed in Q4 2024

Share counts compared with Q3 2024: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
0
Added
0
Reduced
0
Sold out
1
Est. −$207.6K

Top 5 holdings

Share of this quarter's portfolio value

  1. INSGInseego Corp.
    100.0%$7.81MHistory

Biggest buys

New and added positions, by estimated amount bought

None this quarter.

Largest weight increases

New and added positions, by percentage points of the portfolio gained

None this quarter.

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. TNGXTango Therapeutics, Inc.
    −$207.6KSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. TNGXTango Therapeutics, Inc.
    −1.64 pp1.6% → 0.0%History

Metrics

13F metrics for Q4 2024, computed only from the numbers in the filings. Definitions below.

Portfolio value
$7.81M
−$4.83M (−38.2%) vs. prior quarter
Positions
1
−1 vs. prior quarter
Top 10 concentration
100.0%
Top 10 as share of value
Turnover
0.0%
Q4 2024, one quarter
Average holding period
2.0 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2023), so positions held before then are understated.

13F filings by quarter

5 quarters, going back to Q4 2023. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $186.2M (Q4 2023)

Q4 2023: $186.2MQ1 2024: $2.35MQ2 2024: $8.35MQ3 2024: $12.6MQ4 2024: $7.81M
Q4 2023Q4 2024
13F filings of Braslyn Ltd. by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q4 2024Feb 14, 20251$7.81MINSGvs. Q3 2024SEC
Q3 2024Nov 14, 20242$12.6MINSGTNGXvs. Q2 2024SEC
Q2 2024Aug 14, 20242$8.35MINSGTNGXvs. Q1 2024SEC
Q1 2024May 15, 20242$2.35MINSGTNGXvs. Q4 2023SEC
Q4 2023Feb 14, 20243$186.2MMRTXINSGTNGX–SEC